Imgatuzumab clearly induced CDC in high EGFR expressing A431 cells, suggesting that membranous EGFR levels in our NSCLC cell line panel were too low for anti-EGFR antibody-induced CDC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.